You're reading the free version. Trader adds the live tape and alerts.
Start tracking
STOK Exercise Disclosure
Kaye Edward M. Md · SEC Form 4 · Filed Aug 18, 2026
Exercise
Calculated transaction value
$0
Kaye Edward M. Md Director
STOK
Stoke Therapeutics
STOK
Transaction date
Aug 14, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 4 days later
STOK daily price context
Close on/before transaction
$31.27
Aug 14, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Performance Stock Units on Common Stock
- Quantity / price
- 26,250 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001522780-26-000007
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$402.53K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Stoke Therapeutics, Inc. STOK | Sale | Aug 18, 2026 | $381.85K |
| Stoke Therapeutics, Inc. STOK | Sale | Aug 18, 2026 | $20.68K |
| Stoke Therapeutics, Inc. STOK | Exercise | Aug 14, 2026 | $0 |
| Stoke Therapeutics, Inc. STOK Current | Exercise | Aug 14, 2026 | $0 |